All Updates

All Updates

icon
Filter
Funding
Helaina raises USD 45 million in Series B funding to accelerate commercialization
Plant-based Dairy & Egg
Sep 25, 2024
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Product updates
Microsoft launches Copilot Actions for workplace automation
Foundation Models
Yesterday
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
Plant-based Dairy & Egg

Plant-based Dairy & Egg

Sep 25, 2024

Helaina raises USD 45 million in Series B funding to accelerate commercialization

Funding

  • Biotechnology company Helaina has raised USD 45 million in Series B funding led by Avidity Partners, with participation from Spark Capital, Ingeborg Investments, Tom Williams of Heron Rock, Barrel Ventures, Siam Capital, Relish Works, CF Private Equity, and Primary Venture Partners, among others. The funding brings Helaina's total equity funding to USD 83 million.

  • The new funding will be used to scale the availability of effera Human Lactoferrin, a novel ingredient that supports women's health, active nutrition, and healthy aging. Helaina plans to sell effera to consumer brands and through strategic distribution partners.

  • Helaina's effera is claimed to be the first and only human equivalent bioactive protein for nutrition to be used in functional foods, beverages, and supplements. The company has plans to make it available in several consumer products, including those from Kroma Wellness, The Feed, Levelle Nutrition, Healthgevity, and through distributor Mitsubishi International Food Ingredients, Inc.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.